相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elucidation of the alpha-Keto-Aldehyde Binding Mechanism: A Lead Structure Motif for Proteasome Inhibition
Melissa Ann Graewert et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Proteasome inhibitory activity of thiazole antibiotics
Bulbul Pandit et al.
CANCER BIOLOGY & THERAPY (2011)
The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity
Jerome Clerc et al.
CHEMICAL COMMUNICATIONS (2011)
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
B. C. Potts et al.
CURRENT CANCER DRUG TARGETS (2011)
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
D. Chen et al.
CURRENT CANCER DRUG TARGETS (2011)
Subcapsular Fetal Pig Pancreas Fragment Transplantation Provides Normal Blood Glucose Control in a Preclinical Model of Diabetes
Wayne J. Hawthorne et al.
TRANSPLANTATION (2011)
Salinosporamide Natural Products: Potent 20 S Proteasome Inhibitors as Promising Cancer Chemotherapeutics
Tobias A. M. Gulder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
Christopher Blackburn et al.
BIOCHEMICAL JOURNAL (2010)
Proteasome inhibitors: Dozens of molecules and still counting
Geoffroy de Bettignies et al.
BIOCHIMIE (2010)
Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome
Christopher Blackburn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Proteasome inhibition: A new therapeutic strategy to cancer treatment
William Ka Kei Wu et al.
CANCER LETTERS (2010)
20S Proteasome Inhibition: Designing Noncovalent Linear Peptide Mimics of the Natural Product TMC-95A
Michael Groll et al.
CHEMMEDCHEM (2010)
Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets
R. Valdes-Gonzalez et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry
E. Genin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Lawrence R. Dick et al.
DRUG DISCOVERY TODAY (2010)
Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors
Michael Screen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Scytonemides A and B, Cyclic Peptides with 20S Proteasome Inhibitory Activity from the Cultured Cyanobacterium Scytonema hofmanii
Aleksej Krunic et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Comparison of the Effect of Calpain Inhibitors on Two Extralysosomal Proteinases: The Multicatalytic Proteinase Complex and m-Calpain
Maria E. Figueiredo-Pereira et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Pseudomonas syringae Virulence Factor Syringolin A Counteracts Stomatal Immunity by Proteasome Inhibition
Barbara Schellenberg et al.
MOLECULAR PLANT-MICROBE INTERACTIONS (2010)
Inhibition of the Ubiquitin-Proteasome System by Natural Products for Cancer Therapy
Sachiko Tsukamoto et al.
PLANTA MEDICA (2010)
The 26S proteasome: assembly and function of a destructive machine
Nerea Gallastegui et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Bortezomib in Kidney Transplantation
Rajeev Raghavan et al.
JOURNAL OF TRANSPLANTATION (2010)
The Role of Ubiquitin in NF-kappa B Regulatory Pathways
Brian Skaug et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
Daniel Finley
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Discovery and development of the anticancer agent salinosporamide A (NPI-0052)
William Fenical et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Francesco Parlati et al.
BLOOD (2009)
Biosynthesis of the proteasome inhibitor syringolin A: the ureido group joining two amino acids originates from bicarbonate
Christina Ramel et al.
BMC BIOCHEMISTRY (2009)
Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild-Type and Bortezomib-Adapted Leukaemic Cell Lines
Jerome Clerc et al.
CHEMBIOCHEM (2009)
Proteasome inhibition for antibody-mediated rejection
Jason J. Everly et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
The 26 S Proteasome: From Basic Mechanisms to Drug Targeting
Ami Navon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Snapshots of the Fluorosalinosporamide/20S Complex Offer Mechanistic Insights for Fine Tuning Proteasome Inhibition
Michael Groll et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
Han-Jie Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Antiprotealide Is a Natural Product
Rama Rao Manam et al.
JOURNAL OF NATURAL PRODUCTS (2009)
Inhibitors selective for mycobacterial versus human proteasomes
Gang Lin et al.
NATURE (2009)
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel et al.
NATURE MEDICINE (2009)
FoxM1 Is a General Target for Proteasome Inhibitors
Uppoor G. Bhat et al.
PLOS ONE (2009)
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition
Jerome Clerc et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Xenotransplantation of solid organs in the pig-to-primate model
Burcin Ekser et al.
TRANSPLANT IMMUNOLOGY (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
Andreas A. Argyriou et al.
BLOOD (2008)
Structural Basis for Activation and Inhibition of the Secreted Chlamydia Protease CPAF
Zhiwei Huang et al.
CELL HOST & MICROBE (2008)
Joining the army of proteasome inhibitors
Alexei F. Kisselev
CHEMISTRY & BIOLOGY (2008)
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis
John Hines et al.
CHEMISTRY & BIOLOGY (2008)
Structural Analysis of Spiro β-Lactone Proteasome Inhibitors
Michael Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism
Michael Groll et al.
NATURE (2008)
Diversity of degradation signals in the ubiquitin-proteasome system
Tommer Ravid et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Proteasome inhibitors: Poison's and remedies
Silke Meiners et al.
MEDICINAL RESEARCH REVIEWS (2008)
Marine Actinomycetes: A New Source of Compounds against the Human Malaria Parasite
Jacques Prudhomme et al.
PLOS ONE (2008)
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva et al.
BLOOD (2008)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
Identification of genes involved in the biosynthesis of the cytotoxic compound glidobactin from a soil bacterium
Barbara Schellenberg et al.
ENVIRONMENTAL MICROBIOLOGY (2007)
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome
Susan D. Demo et al.
CANCER RESEARCH (2007)
Regulation of CD8+ T cell development by thymus-specific proteasomes
Shigeo Murata et al.
SCIENCE (2007)
Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice
Gloria Bonuccelli et al.
CELL CYCLE (2007)
Cinnabaramides A-G:: Analogues of lactacystin and salinosporamide from a terrestrial streptomycete
Marc Stadler et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome
Katherine A. Reed et al.
JOURNAL OF NATURAL PRODUCTS (2007)
The ubiquitin pathway is required for innate immunity in Arabidopsis
Sandra Goritschnig et al.
PLANT JOURNAL (2007)
Total synthesis of lactacystin and salinosporamide A
Masakatsu Shibasaki et al.
CHEMISTRY-AN ASIAN JOURNAL (2007)
20S proteasome and its inhibitors: Crystallographic knowledge for drug development
Ljudmila Borissenko et al.
CHEMICAL REVIEWS (2007)
Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition
Cord Naujokat et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis
C. S. Coleman et al.
CELL PROLIFERATION (2006)
Transcriptional changes in powdery mildew infected wheat and Arabidopsis leaves undergoing syringolin-triggered hypersensitive cell death at infection sites
Kathrin Michel et al.
PLANT MOLECULAR BIOLOGY (2006)
Protein polyubiquitination plays a role in basal host resistance of barley
Wubei Dong et al.
PLANT CELL (2006)
A bacterial virulence protein suppresses host innate immunity to cause plant disease
Kinya Nomura et al.
SCIENCE (2006)
α,β-unsaturated β-silyl imide substrates for catalytic, enantioselective conjugate additions:: A total synthesis of (+)-lactacystin and the discovery of a new proteasome inhibitor
Emily P. Balskus et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding
M Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate
AF Kisselev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inhibitor-binding mode of homobelactosin C to proteasomes: New insights into class I MHC ligand generation
M Groll et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate
GQ Hu et al.
MOLECULAR MICROBIOLOGY (2006)
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
M Groll et al.
STRUCTURE (2006)
Total synthesis of natural tert-alkylamino hydroxy carboxylic acids
SH Kang et al.
CHEMICAL REVIEWS (2005)
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
D Chauhan et al.
CANCER CELL (2005)
New cytotoxic salinosporamides from the marine actinomycete Salinispora tropica
PG Williams et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites
C Lindenthal et al.
PARASITOLOGY (2005)
An efficient, stereocontrolled synthesis of a potent omuralide-salinosporin hybrid for selective proteasome inhibition
LR Reddy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Structure-activity relationship studies of salinosporamide a (NPI-0052), a novel marine derived proteasome inhibitor
VR Macherla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Total synthesis of (+)-belactosin A
A Armstrong et al.
CHEMICAL COMMUNICATIONS (2004)
Feasibility of xeno-transplantation
R Hoerbelt et al.
SURGICAL CLINICS OF NORTH AMERICA (2004)
Binding mode of TMC-95A analogues to eukaryotic 20S proteasome
M Kaiser et al.
CHEMBIOCHEM (2004)
A concise, total synthesis of the TMC-95A/B proteasome inhibitors
BK Albrecht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Enantioselective total syntheses of belactosin A, belactosin C, and its homoanalogue
OV Larionov et al.
ORGANIC LETTERS (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Functional analysis of genes involved in the synthesis of syringolin A by Pseudomonas syringae pv. syringae B301D-R
H Amrein et al.
MOLECULAR PLANT-MICROBE INTERACTIONS (2004)
Stereocontrolled synthesis of 3-(trans-2-aminocyclopropyl)alanine, a key component of belactosin A
A Armstrong et al.
ORGANIC LETTERS (2003)
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes
S Meiners et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Total synthesis of TMC-95A
M Inoue et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora
RH Feling et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Proteasome inhibitors as new anticancer drugs
J Adams
CURRENT OPINION IN ONCOLOGY (2002)
Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments
TJ Mincer et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
The structure of the mammalian 20S proteasome at 2.75 Å resolution
M Unno et al.
STRUCTURE (2002)
Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome
M Groll et al.
CHEMISTRY & BIOLOGY (2002)
Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341
JA Fleming et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Crystal structure of the 20 S proteasome: TMC-95A complex: A non-covalent proteasome inhibitor
M Groll et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors
T Nazif et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Antigen processing by the proteasome
PM Kloetzel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Lack of proteasome active site allostery as revealed by subunit-specific inhibitors
J Myung et al.
MOLECULAR CELL (2001)
Structures of TMC-95A-D:: Novel proteasome inhibitors from Apiospora montagnei Sacc. TC 1093
J Kohno et al.
JOURNAL OF ORGANIC CHEMISTRY (2000)
Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of α′,β′-epoxyketone proteasome inhibitors
M Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
分享论文
